Product Images Atzumi

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 23 images provide visual information about the product associated with Atzumi NDC 76978-101 by Satsuma Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - atzumi 01

Figure - atzumi 02

This text provides information on the estimated probability of response to study medication (Dihydroergotamine Mesylate) over time in Studies 1 and 2. The data includes the number of participants in each group (208 for Dihydroergotamine Mesylate and 200 for Placebo) and the time from the first dose in hours for analysis.*

Figure - atzumi 03

This text provides information on the percentage of response to study medication in Studies 3 and 4, comparing Dihydroergotamine Mesylate to Placebo. The data is presented over a period of time from the first dose in hours (1, 2, 3, and 4 hours).*

Figure - atzumi 04

This text provides data from a clinical study comparing Dihydroergotamine Mesylate with a Placebo, where the efficacy is measured over time (0, 4, 8, 12 hours after the first spray). The study involved a sample size of 305 for Dihydroergotamine Mesylate and 300 for Placebo.*

Image - atzumi 05

This description is not available.*

Image - atzumi 06

This is a Protective Foil Pouch designed to keep items safe from environmental factors. The pouch features tear notches on the front and back for easy opening. It also includes space to write the expiration date of the contents. Ideal for storing small items or products that need protection.*

Image - atzumi 07

Store in protective foil pouch until ready to use.*

Image - atzumi 08

Image - atzumi 09

Image - atzumi 10

Image - atzumi 11

Image - atzumi 12

Image - atzumi 13

Image - atzumi 14

This text provides instructions for using a white air pump to clear a nostril. It suggests squeezing the pump three times into one nostril while inhaling through the nose. It also includes guidance on the timing for each squeeze and the associated inhalation, followed by release.*

Image - atzumi 15

Image - atzumi 16

This text provides instructions on how to administer the remaining loose powdered medicine into the same nostril.*

Image - atzumi 17

Image - atzumi 18

Image - atzumi 19

Image - atzumi 20

This text is not available.*

Image - atzumi 21

PRINCIPAL DISPLAY PANEL - 5.2 mg Bottle Carton - atzumi 22

PRINCIPAL DISPLAY PANEL - 5.2 mg Device Pouch Label - atzumi 23

This is important information about a medication called Atzumi (dihydroergotamine) nasal powder with a strength of 5.2mg. It is intended for nasal use only and should be discarded after use. The package contains 1 prefilled single-dose device and the storage instructions are to keep it in its protective pouch at room temperature. The text provides clear instructions on how to use Atzumi, including steps such as blowing your nose, inserting the nozzle into your nostril, and squeezing the air pump to deliver the powdered medicine. The Quick Reference Guide is included with details on how to properly use the device and discard it after use.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents